CHRONIC GRANULOMATOUS DISEASE (CGD)
Clinical trials for CHRONIC GRANULOMATOUS DISEASE (CGD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE (CGD) trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE (CGD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Base Editing' to fix faulty immune cells
Disease control Recruiting nowThis study is testing a new gene-editing treatment for adults with a rare, inherited immune disorder called X-linked chronic granulomatous disease (X-CGD). Doctors will collect a patient's own blood stem cells, use a precise gene-editing tool called 'base editing' to try to fix t…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
NIH launches major study to map mysterious immune diseases
Knowledge-focused Recruiting nowThis study aims to observe and understand how rare immune system disorders progress over time. It will enroll up to 3,500 people, including patients with conditions like Severe Combined Immunodeficiency (SCID), their family members, and healthy volunteers. Researchers will collec…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists map immune defenses in rare disease patients
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system in people with Chronic Granulomatous Disease (CGD), a rare genetic condition that weakens the body's ability to fight infections. Researchers will collect blood samples from about 60 adults and children with CGD to measure the…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC